Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
30,767,343
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
4,410,025
-
Shares change
-
+1,864,047
-
Total reported value, excl. options
-
$33,425,690
-
Value change
-
+$13,189,450
-
Number of buys
-
28
-
Number of sells
-
22
-
Price
-
$7.58
Institutional Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q2 2019
As of 30 Jun 2019 XBiotech Inc. - Common Shares, no par value (XBIT) had 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,410,025 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, Sofinnova Investments, Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Balyasny Asset Management LLC, NORTHERN TRUST CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and EAM Investors, LLC.
This table shows 56 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.